FluoroPharma Medical, Inc. (OTCQB: FPMI) is a biopharmaceutical company with its focus in developing proprietary PET imaging products that can evaluate disease at the cellular and molecular levels. FluoroPharma’s aim is to enable more accurate disease diagnosis at the earliest stages through the use of these advanced imaging products – ultimately improving the management and treatment of disease, as well as patient outcomes. For further information, visit the company’s Web site at www.fluoropharma.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below: